Literature DB >> 16493163

Update in pulmonary hypertension 2005.

Marius M Hoeper1, Lewis J Rubin.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16493163     DOI： 10.1164/rccm.2512003

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  7 in total

1.  Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.

Authors:  Oleg V Evgenov; Daniel S Kohane; Kenneth D Bloch; Johannes-Peter Stasch; Gian P Volpato; Evangelia Bellas; Natalia V Evgenov; Emmanuel S Buys; Mark J Gnoth; Amanda R Graveline; Rong Liu; Dean R Hess; Robert Langer; Warren M Zapol
Journal:  Am J Respir Crit Care Med       Date:  2007-09-13       Impact factor: 21.405

Review 2.  Physiologic properties and regulation of the actin cytoskeleton in vascular smooth muscle.

Authors:  Dale D Tang; Yana Anfinogenova
Journal:  J Cardiovasc Pharmacol Ther       Date:  2008-01-22       Impact factor: 2.457

Review 3.  p130 Crk-associated substrate (CAS) in vascular smooth muscle.

Authors:  Dale D Tang
Journal:  J Cardiovasc Pharmacol Ther       Date:  2009-03-27       Impact factor: 2.457

4.  Abl knockout differentially affects p130 Crk-associated substrate, vinculin, and paxillin in blood vessels of mice.

Authors:  Shu Chen; Ruping Wang; Qing-Fen Li; Dale D Tang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-19       Impact factor: 4.733

5.  Prevention of bronchial hyperreactivity in a rat model of precapillary pulmonary hypertension.

Authors:  Walid Habre; Gergely Albu; Tibor Z Janosi; Fabienne Fontao; Britta S von Ungern-Sternberg; Maurice Beghetti; Ferenc Petak
Journal:  Respir Res       Date:  2011-04-27

6.  Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension.

Authors:  Kamrun Nahar; Shahriar Absar; Nilesh Gupta; Venkata Ramana Kotamraju; Ivan F McMurtry; Masahiko Oka; Masanobu Komatsu; Eva Nozik-Grayck; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2014-11-04       Impact factor: 4.939

7.  Pulmonary arterial remodeling induced by a Th2 immune response.

Authors:  Eleen Daley; Claire Emson; Christophe Guignabert; Rene de Waal Malefyt; Jennifer Louten; Viswanath P Kurup; Cory Hogaboam; Laimute Taraseviciene-Stewart; Norbert F Voelkel; Marlene Rabinovitch; Ekkehard Grunig; Gabriele Grunig
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.